3 results
Approved WMOCompleted
To determine the activity (as measured by objective response rate by RECIST1.1) of monalizumab and trastuzumab in patients with metastatic HER2-positive breast cancer.
Approved WMORecruiting
To assess whether the use of the personalized risk assessment tool (PERSARC) is (cost)effective in reducing decisional conflict and increasing informed choices in high-grade extremity STS compared to usual care (co-primary outcomes). In addition, we…
Multi-Center Clinical Evaluation of the ATTUNE® Cementless Rotating Platform Total Knee Arthroplasty
Primary objectives:- Investigate the change from pre-operative baseline to two year postoperative functional performance improvement for the ATTUNE Primary, Cementless TKA RP system as measured with the KOOS questionnaire (KOOS-ADL sub-score). This…